nav arrow

CogWellin LLC is a pharmaceutical development and testing company dedicated to preventing, slowing and reversing Alzheimer's Disease, Traumatic Brain Injury, Chronic Traumatic encephalopathy as well as Type II diabetes. What do all of these illness have in common? All are characterized by overabundance of poisonous process called "inflammation". It is the destruction of vital cells in the body (brain, pancreas and other organs) caused by the inflammation that results in serious and often life threatening consequences of these illnesses which afflict more than 500 million individuals worldwide. Our provisionally patented reformulation of salsalate (two molecules of nature's safest and most potent anti-inflammatory medicine called salicylic acid) will revolutionize the management of these disorders. At CogWellin we in are in the final steps to complete the development and begin human testing of a once daily long acting, safe and therapeutic reformulation of salsalate. At CogWellin we are developing a home based blood testing and reporting kit for optimizing and personalizing each patient's blood level of salicylate. It will be the best and safest all naturally derived approach to improved the quality of lives of hundreds of millions of individuals worldwide batting Alzheimer's Disease, Traumatic Brain Injury, Chronic Traumatic Encephalopathy and Type II diabetes.

More About Us

Science

science icon

Salicylic acid has been used for over 2000 years to help mankind battle illnesses. CogWellin™ has taken salicylic acid into the 21st century by formulating it into a once-daily, long-acting capsule.

Read More

Studies

studies icon

If CogWellin™ is well tolerated and is shown to reduce levels of Ac-Tau, three ambitious phase II/III studies will be done hopefully leading the FDA approval of the first Alzheimer's disease modifying and prevention drug.

Read More